We were thrilled to participate in the PROMETHEUS Re-Treat on July 26th in Washington DC, where our Director, Robert Grossman, represented us for the launch of the Prometheus Data Platform (PDP 1.0). This project, led by the Open Commons Consortium, a division of the Center for Computational Science Research Inc (CCSR), in collaboration with our partner, The Center for Translational Data Science at the University of Chicago, marks a significant milestone. Kudos to both teams for their hard work bringing the PDP to life!
PROMETHEUS, which stands for PROject for Military Exposures and Toxin History Evaluation in US Service Members, aims to discover and study advanced precision technologies to prevent, detect early, and enhance treatments for cancers potentially arising from environmental contaminants and toxin hazards faced by military service members and veterans.
Our vision is to integrate federal scientific platforms with public-private innovators to reveal the impact of service-related exposures to environmental contaminants and toxin hazards, and to develop prevention and early detection approaches, as well as advanced treatments for cancers arising from these exposures.
The PDP includes the BLOODPAC Data Commons and the Veterans Precision Oncology Data Commons (VPODC). It also interoperates with the NCI Genomics Data Commons (GDC), Proteomic Data Commons (PDC), and The Cancer Imaging Data Commons (TCIA), all of which have APIs enabling seamless integration with the PDP. These integrations support Apollo data.
The PDP not only provides an environment for PROMETHEUS researchers but also offers a fit-for-purpose governance structure in support of the White House Cancer Moonshot 2.0 data-sharing principles.
Explore the Prometheus Data Platform version 1.0 (PDP) here: PDP 1.0.
This is just the beginning!